$ANGO 4/A SEC Filings

Filed On	Filing
21 Sep 2023	Form 4/A: Centea Scott, SVP/GM, VIT Received 7,539 shares by exercise or conversion · Gave up 2,716 shares to cover exercise price or tax ($24.2K)
21 Sep 2023	Form 4/A: Campbell Chad Thomas, SVP/GM, Vascular Access Received 8,610 shares by exercise or conversion · Gave up 3,103 shares to cover exercise price or tax ($27.7K)
21 Sep 2023	Form 4/A: Clemmer James C, Director Received 69,676 shares by exercise or conversion · Gave up 34,296 shares to cover exercise price or tax ($306K)
21 Sep 2023	Form 4/A: Trowbridge Stephen A, EVP and CFO Received 19,354 shares by exercise or conversion · Gave up 6,975 shares to cover exercise price or tax ($62.2K)
21 Sep 2023	Form 4/A: Helsel Dave, SVP Global Operations and R&D Received 9,650 shares by exercise or conversion · Gave up 3,477 shares to cover exercise price or tax ($31K)
30 Dec 2021	Form 4/A: Helsel Dave, SVP Global Operations and R&D Granted 11,026 Non-Qualified Stock Option (right to buy)
30 Dec 2021	Form 4/A: Clemmer James C, Director Received 37,420 shares as a grant or award · Granted 74,840 Performance Right · Granted 101,667 Non-Qualified Stock Option (right to buy)
30 Dec 2021	Form 4/A: Centea Scott, SVP/GM, VIT Granted 5,684 Performance Right · Granted 7,721 Non-Qualified Stock Option (right to buy)
30 Dec 2021	Form 4/A: Campbell Chad Thomas, SVP/GM, Vascular Access Granted 11,923 Non-Qualified Stock Option (right to buy)
30 Dec 2021	Form 4/A: Trowbridge Stephen A, EVP and CFO Granted 20,128 Non-Qualified Stock Option (right to buy)
30 Dec 2021	Form 4/A: Rosenzweig Richard C, SVP and General Counsel Granted 6,197 Peformance Right · Granted 8,418 Non-Qualified Stock Option (right to buy)
18 Aug 2021	Form 4/A: Campbell Chad Thomas, SVP/GM, Vascular Access Received 8,210 shares by exercise or conversion · Gave up 3,130 shares to cover exercise price or tax ($85.4K)
18 Aug 2021	Form 4/A: Clemmer James C, Director Received 40,528 shares by exercise or conversion · Gave up 21,532 shares to cover exercise price or tax ($588K)
18 Aug 2021	Form 4/A: Trowbridge Stephen A, EVP and CFO Received 10,946 shares by exercise or conversion · Gave up 4,173 shares to cover exercise price or tax ($114K)
18 Aug 2021	Form 4/A: Helsel Dave, SVP Global Operations and R&D Received 11,406 shares by exercise or conversion · Gave up 3,347 shares to cover exercise price or tax ($91.3K)
16 Jul 2019	Form 4/A: Meteny Dennis S, Director Received 6,650 shares by exercise or conversion ($71K) · Gave up 3,607 shares to cover exercise price or tax ($71K)
15 May 2012	Form 4/A: Bucci Vincent, Director Bought 2,000 shares ($23.7K)
02 Feb 2011	Form 4/A: McGill Stephen, SVP, GM - International Received 10,000 shares as a grant or award · Gave up 1,025 shares to cover exercise price or tax ($16.6K) · Granted 40,000 Non-Qualified Stock Option
30 Aug 2010	Form 4/A: McCarthy Shawn P, SVP - General Manager Gave up 1,358 shares to cover exercise price or tax ($21.8K)
19 Jan 2007	Form 4/A: Mitchell Robert D, Executive VP and COO Granted 40,800 Non-Qualified Stock Option (right to buy)

Comments